Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia

Published:2016-05 Issue:3 Volume:30 Page:201-211
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Torka Pallawi,Al Ustwani Omar,Wetzler Meir,Wang Eunice S.,Griffiths Elizabeth A.

Funder

National Cancer Institute Grant

Szefel Foundation

Leonard S. LuVullo Endowment for Leukemia Research

Nancy C. Cully Endowment for Leukemia Research

Babcock Family Endowment

Heidi Leukemia Research Fund

Roswell Park Alliance Foundation

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference68 articles.

1. Delicious poison: arsenic trioxide for the treatment of leukemia;Kwong;Blood,1997

2. Ai-Lin I treated 32 cases of acute promyelocytic leukemia;Sun;Chin J Integr Chin West Med,1992

3. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients;Shen;Blood,1997

4. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710;Powell;Blood,2010

5. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia;Lo-Coco;N Engl J Med,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of p62-Keap1-Nrf2 Pathway Activation by Realgar Promotes the Inhibition of Esophageal Cancer Cell Proliferation, Migration, and Ferroptosis;Current Drug Delivery;2022-12-26

2. Exploring the Mechanism of Realgar against Esophageal Cancer Based on Ferroptosis Induced by ROS-ASK1-p38 MAPK Signaling Pathway;Evidence-Based Complementary and Alternative Medicine;2022-09-12

3. A practical strategy to subcutaneous administered in-situ gelling co-delivery system of arsenic and retinoic acid for the treatment of acute promyelocytic leukemia;Asian Journal of Pharmaceutical Sciences;2021-09

4. Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic);Arthritis Research & Therapy;2021-03-03

5. Arsenic—rice—human health: Understanding the toxic association from microbiome angle;New and Future Developments in Microbial Biotechnology and Bioengineering;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3